Indian subcontinent) from Eastern Slovakia (Min á rik et al, 2003) and Spain ( Á lvarez et al, 2005) . This mutation was also shown to have a high carrier frequency (2.4%) in the Indian population (RamShankar et al, 2003) , and in some subpopulations of Gypsies (Min á rik et al, 2003; Á lvarez et al, 2005) .
Due to the high frequency of GJB2 mutations among NSHL cases in several populations worldwide, mutation analysis of this gene is a widely available genetic test, representing the fi rst step in the molecular diagnosis of this pathology.
Since most GJB2 mutations described so far localize to the coding region (totally included within exon 2), only this region has been systematically analysed. Nonetheless, a few noncoding pathogenic mutations have already been identifi ed, contributing to the elucidation of the genetic etiology of the HL in some patients who harboured only one recessive mutation in the GJB2 coding region (Denoyelle et al, 1999; Mani et al, 2009; Matos et al, 2007) .
We present here a comprehensive molecular analysis of the GJB2 gene in a cohort of 264 Portuguese NSSHL patients.
Materials and Methods

Patients
A total of 264 Portuguese unrelated individuals (sporadic and familial cases), presenting with bilateral mild to profound NSSHL were tested for the presence of mutations in the DFNB1 locus. They had been referred over the last ten years, from various otolaryngology departments and genetic units, and come from different regions of the country. A recessive mode of inheritance was predominantly observed in the familial cases.
Diagnosis of NSSHL was established by accepted clinical criteria. Infection, oto-trauma, or neonatal diseases causing acquired deafness were excluded by collecting detailed clinical history. Individuals referred as not having been born in Portugal were also not considered.
Written informed consent was obtained from all the participants, or from parents in case of those younger than 18 years.
Audiological methods
All patients involved in the study underwent otoscopic and audiometric examinations by using age-appropriate methods. Pure-tone audiometry, tympanometry and auditory brainstem response were obtained in a sound-proof room according to current clinical standards. We were not able to retrieve medical history and audiometric records for all the patients. For some patients family histories were unknown.
Molecular analysis
Blood samples were obtained from most subjects. DNA extraction from whole blood has been performed since the beginning of the study using either Quiagen or JetQuick DNA extraction kits. For some patients DNA was extracted from buccal swabs using the Chelex method.
All DNA samples were fi rst screened for the c.35delG mutation by PCR-mediated site-directed mutagenesis (PSDM) followed by restriction fragment length polymorphism (RFLP) analysis (Storm et al, 1999) .
The c.35delG homozygotes were diagnosed as having GJB2 -related HL and, consequently, no other studies were performed.
Initially, the c.35delG heterozygotes and the negative cases had been screened by single-strand conformational polymorphism (SSCP) analysis, according to Scott et al (1998) , followed by sequencing of the relevant GJB2 fragment. In more recent years, all new cases falling into the two above mentioned situations have instead been analysed by direct sequencing of the entire coding region and fl anking acceptor splice site, as previously described . Those c.35delG heterozygotes fi rst analysed by SSCP and in which no second variant had been identifi ed, as well as 29 of the 105 c.35delG negative cases which revealed no changes in the subsequent SSCP analysis, were further sequenced for the entire coding region and fl anking acceptor splice site.
If the cause of deafness remained non-elucidated, the patients were then screened for the del( GJB6 -D13S1830) and del( GJB6 -D13S1854) GJB6 deletions using multiplex PCR, as described in the literature (del Castillo FJ et al, 2005) . Twelve cases could not be analysed for any of the GJB6 deletions (eight cases negative for GJB2 mutations plus four c.35delG heterozygotes), and two cases (both negative for GJB2 mutations) could only be screened for del( GJB6 -D13S1830), since the corresponding DNAs had meanwhile run out, or had degraded, especially those DNAs extracted from buccal swabs.
Ninety patients among those found not to harbour any GJB6 deletion have been screened by sequencing for mutations in the GJB2 basal promoter, exon 1 and donor splice site. Results concerning 83 of these 90 patients have been reported (Matos et al, 2007 (Matos et al, , 2008 (Matos et al, , 2011 .
Results
At least one out of 21 different GJB2 variants (18 coding and three noncoding) was found in 80 (30.2%) of the 264 patients representing a total of 133/528 (25%) mutated alleles (see Table 1 ). All the variants here identifi ed were previously described, with the exception of the novel variant c.24G Ͼ A, which results in a silent mutation at protein level (p.T8T). Two of the reported mutations (c.-259C Ͼ T and p.M163L), listed in Table 1 , were fi rst identifi ed in Portuguese patients (Matos et al, 2008 (Matos et al, , 2007 included in the sample under analysis. As expected, c.35delG was the mutation most frequently found amongst the NSSHL patients, being present in 84 of the 528 chromosomes analysed, which corresponds to a prevalence of 15.9% (see Table 1 ) and a frequency of 63% of all mutated alleles. Twenty-seven out of 264 (10.2%) probands harboured only one GJB2 variant. Subsequent analysis revealed that the GJB6 deletion del( GJB6 -D13S1854) was present in two of those patients (one heterozygous for c.35delG plus one heterozygous for p.M34T), both with prelingual, profound HL. One other patient solely harboured the dominant p.M163L mutation which has been previously described (Matos et al, 2008) .
Discussion
A wide spectrum of GJB2 variants, mostly pathogenic, was observed in the cohort of 264 NSSHL Portuguese individuals included in this study. Some variants of unclear effect (insuffi cient published data to infer pathogenicity) or of controversial pathogenicity (contradictory published data regarding pathogenicity) were also identifi ed.
The DFNB1 genotype explained the HL, or was a likely cause of the pathology, in 20.8% (55/264) of the cases. All but two of these cases (53/55), corresponding to 20.8% of all the patients analysed, were presumed to be due to the GJB2 genotype and thus considered as GJB2 -related HL. For the remaining two patients (2/55) the HL could be explained by the presence of a coding GJB2 mutation (c.35delG or c.Met34Thr) and the GJB6 del( GJB6 -D13S1854), both in heterozygosity. The GJB2 -related cases also include the patient harbouring the above referred dominant p.M163L mutation (Matos et al, 2008) . Noteworthy, the HL in three patients with one coding GJB2 mutation was explained by the presence of a second GJB2 mutation in the basal promoter (c.-259C Ͼ T) or in the donor splice site (c.-23 ϩ 1G Ͼ A). To our knowledge, the c.-259C Ͼ T mutation is so far restricted to the Portuguese family here presented. This mutation was not found in 91 normal-hearing Portuguese individuals from the general population (Matos et al, 2011 ) and reporter gene assays have shown that the mutation greatly impairs the promoter function (Matos et al, 2007) .The fi nding of GJB2 pathogenic mutations in the basal promoter and donor splice site highlights the relevance of screening those noncoding regions in addition to the coding region.
The deletion c.35delG was the predominant GJB2 mutation among GJB2 -related HL cases, in accordance with other European, or of mainly European descent populations (Dal á mon et al, 2010; Pandya et al, 2003; Roux et al, 2004) . Individuals homozygous for the c.35delG mutation accounted for about 53% of the GJB2 -related HL cases, and represented 10.6% of the total Portuguese NSSHL patients. This predominance had also been observed in a different study conducted on a small number (n ϭ 53) of NSHL Portuguese patients (Nogueira et al, 2011) , and in a sample of 100 Portuguese cochlear implanted children, in which GJB2 genotype was shown to correlate to better oral performance (Chora et al, 2011) .
Interestingly, the dominant GJB2 mutation p.M163L, causing mild/moderate high-frequency HL (Matos et al, 2008) , has meanwhile also been found in one Argentinean patient presenting with prelingual, profound NSSHL (Dalam ó n et al, 2010), suggesting that the severity of the HL due to the p.M163L mutation might be variable and/or progressive.
As regards the controversial but potentially pathogenic p.M34T (Feldmann et al, 2004; Snoeckx et al, 2005; Bicego et al, 2006; Pollak et al, 2007) 
E1-2 ϭ extracellular domain 1 or 2; M1-4 ϭ transmembrane domain 1, 2, 3, or 4; IC ϭ intracellular domain (between M2 and M3); T ϭ truncating mutation; NT ϭ nontruncating mutation. a Mutations identifi ed for the fi rst time in the Portuguese population; b Mutation up to now private to one Portuguese family; c noncoding variant; d Found in this study only in patients of Gypsy or Indian ethnicity/ancestry; e deletion of one nonterminal codon, thus considered to be a nontruncating mutation.
variant or the del( GJB6 -D13S1854) deletion. Those genotypes were here considered to be the likely cause of the HL, with some reservations regarding the only p.R127H homozygous patient (negative for the GJB6 deletions). Since other hearing-impaired relatives of this patient were not available for study, we cannot know whether the p.R127H homozygous genotype is segregating with HL in the family.
The unclear p. V153I (RamShankar et al, 2003; Me ş e et al, 2004; Snoeckx et al, 2005; Guerci et al, 2007) and p.G160S (Janecke et al, 2002; Snoeckx et al, 2005) were identifi ed in heterozygosity in two of our patients, respectively. No inference regarding the relation of their GJB2 genotype with the HL could be made.
In which concerns genotype-phenotype correlation, truncating (T) mutations are usually associated with a greater degree of HL than nontruncating (NT) mutations (Cryns et al, 2004; Putcha et al, 2007; Snoeckx et al, 2005) . However, variability in the degree of the hearing loss in T/T genotypes has been noticed, and is well exemplifi ed by the signifi cant intra-and inter-familial variation, ranging from mild to profound impairment, observed in c.35delG homozygotes (Cryns et al, 2004; Murgia et al, 1999) . In the present study, the majority (n ϭ 17/23) of homozygotes for c.35delG with a reported phenotype had severe or profound HL, as expected.
As opposed to T/T GJB2 genotypes, NT/NT GJB2 genotypes appear to be often associated with mild or moderate HL (Putcha et al, 2007; Snoeckx et al, 2005) . When considering NT/NT genotypes including at least one p.M34T or p.V37I allele, it was observed that they are usually, but not always, associated with less severe HL (Snoeckx et al, 2005 (Snoeckx et al, 2005) .
Regarding T/NT GJB2 genotypes, the variability on HL degree seems to depend on the NT mutation, at least when the T mutation is c.35delG (an early frameshift mutation). The two patients who were compound heterozygous for the p.V37I and c.35delG displayed mild and moderate HL, respectively, which is in accordance with the phenotypes previously found associated with this compound genotype by Cryns and co-workers (Cryns et al, 2004 (Cryns et al, 2004; Snoeckx et al, 2005) than with less severe HL (Cheng et al, 2005) .
In general, our data meet the view that the severity of GJB2 -related HL can be correlated with specifi c mutation combinations (Cryns et al, 2004; Snoeckx et al, 2005) . Variation in the phenotype for a given genotype would likely be dependent on more than one major modifi er gene, as suggested by the study of Hilgert and co-workers , as well as on environmental factors.
In conclusion, GJB2 mutations are a major cause of NSSHL in the Portuguese population, c.35delG being the predominant mutation, and each of the 19 other pathogenic/controversial variants occurring at much lower frequencies. Screening for the GJB2 donor splice site and basal promoter, and for the two common GJB6 deletions, allowed the elucidation of the HL etiology in some of the cases with only one coding mutation identifi ed. Therefore, such screening, in patients harbouring only one coding mutation, is advisable and should be performed.
Overall, more than one in fi ve of the Portuguese patients have been diagnosed as having DFNB1-related NSSHL. Analysis of GJB2 and GJB6 may thus represent a valuable indicator for clinicians, as regards therapeutical and rehabilitation options, as well as for genetic counselors of Portuguese patients and their families.
In fact, the current clinical assessment of hearing-impaired children/patients includes regular and sometimes invasive clinical investigations due to the possibility of the occurrence of dysfunction in other organs (syndromic HL). A conclusive genetic diagnosis can avoid these follow-ups, leading to a signifi cant reduction of clinical investigations and inherent costs. Furthermore, the higher oral performance scores above referred, obtained in Portuguese cochlear implanted patients with DFNB1-associated deafness, show that individuals with this genetic etiology are good candidates for cochlear implantation, which represents an important prognostic tool.
